# OmniAb, Inc.: overview

OABI · Nasdaq · CIK 1846253 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/oabi.md) · [Financials](/companies/oabi/financials.md) · [Filings](/companies/oabi/filings.md) · [Insiders](/companies/oabi/insiders.md)

Latest reported revenue: [$13.4m](/filings/0001846253-26-000046.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001846253-26-000046).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4.2](/filings/0001628280-25-048923.md) | [10.8 d](/filings/0001846253-26-000009.md) | [4.2](/filings/0001846253-26-000037.md) | [3.9](/filings/0001846253-26-000046.md) | [2.2](/filings/0001628280-25-048923.md) | [8.4 d](/filings/0001846253-26-000009.md) | [14.4](/filings/0001846253-26-000037.md) | [13.4](/filings/0001846253-26-000046.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(473.7%)](/filings/0001628280-25-048923.md) | [(147.0%) d](/filings/0001846253-26-000009.md) | [(453.6%)](/filings/0001846253-26-000037.md) | [(416.2%)](/filings/0001846253-26-000046.md) | [(810.2%)](/filings/0001628280-25-048923.md) | [(188.2%) d](/filings/0001846253-26-000009.md) | [(54.3%)](/filings/0001846253-26-000037.md) | [(49.5%)](/filings/0001846253-26-000046.md) |
| Net margin | % | [(392.4%)](/filings/0001628280-25-048923.md) | [(121.0%) d](/filings/0001846253-26-000009.md) | [(438.1%)](/filings/0001846253-26-000046.md) | [(407.4%)](/filings/0001846253-26-000046.md) | [(738.1%)](/filings/0001628280-25-048923.md) | [(169.3%) d](/filings/0001846253-26-000009.md) | [(53.4%)](/filings/0001846253-26-000046.md) | [(43.7%)](/filings/0001846253-26-000046.md) |
| Diluted EPS | $ per share | [(0.16)](/filings/0001628280-25-048923.md) | not reported | [(0.17)](/filings/0001846253-26-000037.md) | [(0.15)](/filings/0001846253-26-000046.md) | [(0.14)](/filings/0001628280-25-048923.md) | not reported | [(0.06)](/filings/0001846253-26-000037.md) | [(0.05)](/filings/0001846253-26-000046.md) |
| Free cash flow | $m | [(6.7) d](/filings/0001628280-25-048923.md) | [(3.9) d](/filings/0001846253-26-000009.md) | [(16.1)](/filings/0001846253-26-000037.md) | [(5.3) d](/filings/0001846253-26-000046.md) | [(9.9) d](/filings/0001628280-25-048923.md) | [(5.7) d](/filings/0001846253-26-000009.md) | [(5.1)](/filings/0001846253-26-000037.md) | [2.6 d](/filings/0001846253-26-000046.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [34.7](/filings/0001846253-23-000026.md) | [59.1](/filings/0001846253-24-000006.md) | [34.2](/filings/0001846253-25-000024.md) | [26.4](/filings/0001846253-26-000009.md) | [18.7](/filings/0001846253-26-000009.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(102.5%)](/filings/0001846253-23-000026.md) | [(45.1%)](/filings/0001846253-24-000006.md) | [(203.2%)](/filings/0001846253-25-000024.md) | [(282.3%)](/filings/0001846253-26-000009.md) | [(369.5%)](/filings/0001846253-26-000009.md) |
| Net margin | % | [(77.8%)](/filings/0001846253-23-000026.md) | [(37.8%)](/filings/0001846253-24-000006.md) | [(148.2%)](/filings/0001846253-25-000024.md) | [(235.1%)](/filings/0001846253-26-000009.md) | [(347.0%)](/filings/0001846253-26-000009.md) |
| Diluted EPS | $ per share | [(0.33)](/filings/0001846253-23-000026.md) | [(0.26)](/filings/0001846253-24-000006.md) | [(0.51)](/filings/0001846253-25-000024.md) | [(0.61)](/filings/0001846253-26-000009.md) | [(0.57)](/filings/0001846253-26-000009.md) |
| Free cash flow | $m | [(9.7)](/filings/0001846253-23-000026.md) | [(20.8)](/filings/0001846253-24-000006.md) | [0.7](/filings/0001846253-25-000024.md) | [(41.5)](/filings/0001846253-26-000009.md) | [(37.0)](/filings/0001846253-26-000009.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/oabi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Whitefort Capital Management, LP](/funds/1884931.md) | 2026-06-30 | $25.2m | 10,248,658 |  | Reduced −3,975,000 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $21.9m | 8,897,490 |  | Added +790,609 |
| [NOMURA HOLDINGS INC](/funds/1163653.md) | 2026-06-30 | $12.4m | 5,028,160 |  | Added +4,323,112 |
| [CADIAN CAPITAL MANAGEMENT, LP](/funds/1423686.md) | 2026-06-30 | $10.4m | 4,211,821 |  | Added +54,692 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $9.5m | 3,852,356 |  | Reduced −141,296 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $7.1m | 2,883,978 |  | Reduced −41,601 |
| [RICE HALL JAMES & ASSOCIATES, LLC](/funds/1230765.md) | 2026-06-30 | $6.4m | 2,610,434 |  | Added +63,179 |
| [PRIVATE MANAGEMENT GROUP INC](/funds/1142031.md) | 2026-06-30 | $5.8m | 2,344,770 |  | Reduced −84,396 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $5.2m | 2,133,549 |  | Added +66,406 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $3.1m | 1,262,099 |  | Reduced −483,149 |

## Recent filings

[All 381 filings](/companies/oabi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 07:42 ET | [8-K](/filings/0001846253-26-000049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001846253-26-000049 |
| 2026-08-06 | 16:28 ET | [10-Q](/filings/0001846253-26-000046.md) | Quarterly report, period 2026-06-30 | 0001846253-26-000046 |
| 2026-08-06 | 16:11 ET | [8-K](/filings/0001846253-26-000044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001846253-26-000044 |
| 2026-07-13 | 08:06 ET | [8-K](/filings/0001846253-26-000042.md) | 5.02 Departure or appointment of officers or directors | 0001846253-26-000042 |
| 2026-06-18 | 16:29 ET | [8-K](/filings/0001846253-26-000039.md) | 5.07 Shareholder vote results | 0001846253-26-000039 |
| 2026-05-07 | 16:25 ET | [10-Q](/filings/0001846253-26-000037.md) | Quarterly report, period 2026-03-31 | 0001846253-26-000037 |
| 2026-05-07 | 16:13 ET | [8-K](/filings/0001846253-26-000035.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001846253-26-000035 |
| 2026-04-29 | 16:17 ET | [DEF 14A](/filings/0001846253-26-000027.md) | Proxy statement, period 2026-06-17 | 0001846253-26-000027 |
| 2026-03-04 | 16:40 ET | [10-K](/filings/0001846253-26-000009.md) | Annual report, period 2025-12-31 | 0001846253-26-000009 |
| 2026-03-04 | 16:13 ET | [8-K](/filings/0001846253-26-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001846253-26-000006 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001846253-26-000009.md), filed Mar 4, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/bd73de50-d993-4e9c-8dbe-b1098627bd09)

## About the filer

- CIK: 1846253
- Tickers: OABI, OABIW
- Exchange: Nasdaq
- SIC code: 8731 Services-Commercial Physical & Biological Research
- State of incorporation: DE
- Filer category: Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 08:25 ET. No prices; not investment advice.